Title: ASEAN regional workshop on bilateral Free Trade Agreements
1ASEAN regional workshop on bilateral Free Trade
Agreements
Lessons from Latin american experience
Francisco Rossi. IP and access to drugs capacity
building project. UNDP - International poverty
centre. Brasilia. Brazil. Francisco.rossi_at_undp-pov
ertycentre.org
2ASEAN Regional workshop on bilateral Free Trade
Agreements
- The stronger the intellectual property rights,
the better. - Negotiations with USA Pharma.
- Lessons from Latin America
- On impact of IP
- Next steps
3(No Transcript)
4- Trips plus measures are totally legal.
- Countries on FTAs believe on IP
- Countries on FTAs decided sovereignty
- FTAs do not undermine Doha Declaration
- Trips plus is unadequate term
TRIPS PRECISSIONS.
5Drug makers go furthest to sway Congress By Jim
Drinkard, USA TODAY (26/04/05)
- By the numbers158 millionSpending in 2004 to
lobby the federal government.17
millionCampaign contributions in 2004 to federal
candidates (67 to Republicans).7.3
millionSupport for the 2004 political party
conventions (64 to Republicans). estimate
Sources Center for Responsive Politics, Campaign
Finance Institute, Center for Public Integrity
6DIARIO LA REPUBLICA, JUEVES 16 DE SETIEMBRE DEL
2004.
7Intellectual Property Rights, Free Trade
Agreements and Public Health
8(No Transcript)
9TRIPS PLUS MEASURES IN RECENT FREE TRADE
AGREMENTS
10Restrictions on INN (generic names) use
- TRIPS 20
- Other Requirements
- The use of a trademark in the course of trade
shall not be unjustifiably encumbered by special
requirements, such as use with another trademark,
use in a special form or use in a manner
detrimental to its capability to distinguish the
goods or services of one undertaking from those
of other undertakings. This will not preclude a
requirement prescribing the use of the trademark
identifying the undertaking producing the goods
or services along with, but without linking it
to, the trademark distinguishing the specific
goods or services in question of that
undertaking.
- CAFTA
- ARTICLE 15.2 TRADEMARKS
- In view of the obligations of Article 20 of
the TRIPS Agreement, each Party shall ensure that
provisions mandating the use of the term
customary in common language as - the common name for a good (common name)
including, inter alia, requirements concerning
the relative size, placement or style of use of
the trademark in relation to the common name, do
not impair the use or effectiveness of trademarks
used in relation to - such goods.
11Intellectual Property Rights, Free Trade
Agreements and Public Health
Latin American Free Trade Agreements
negotiations. Lessons learned.
12Intellectual Property Rights, Free Trade
Agreements and Public Health
- ON PROCESS
- USTR Agreements administrator.
- Confidentiality
- U.N. support. Carlos Correa Veto.
- C.S.O.
- CONGRESS
- Health sector commitment relations with trade
negotiators
13(No Transcript)
14(No Transcript)
15Intellectual Property Rights, Free Trade
Agreements and Public Health
- AFTA PROPOSALS
- Everything.
- Patents for plants, animals, diagnostic,
chirurgical and therapeutic methods. - Patents for uses
- C.L. restrictions.
- National exhaustion of rights
- AFTA PROPOSALS
- Everything.
- Patent term restorations.
- Linkage
- Data protection
- Restriction on generic names
16Intellectual Property Rights, Free Trade
Agreements and Public Health
- AFTA PROPOSALS
- USA PROPOSAL.
- ANDEAN PROPOSAL. TRIPS-DOHA
- 11 ROUNDS.
- ANDEAN SECOND PROPOSAL
- DATA PROTECTION
- TRANSPARENCY
- PATENT TERM RESTORATION
- Colombian IP Negotiator impasse
- Final political decision?
17(No Transcript)
18(No Transcript)
19(No Transcript)
20Fuente Ramirez M. et al. El gasto en salud de
los hogares Colombianos. Universidad del Rosario.
2002.
21Spent on medicines as a of income .
Households survey. Colombia 1997
Fuente Ramirez M. et al. El gasto en salud de
los hogares Colombianos. Universidad del Rosario.
2002.
22In developed countries the state pays, in
developing the individual!
23(No Transcript)
24IPRC
- The contemporary evidence suggests that, because
developing countries are large net importers of
technology from the developed world, the
globalisation of IP protection will result in
very substantial additional net transfers from
developing to developed countries . - www.iprcommission.org
25(No Transcript)
26Hood Robin
27The stronger the intellectual property rights,
the better.
- Benefits of innovation ARV coverage
- Innovation orientation Neglected diseases
- Innovation or stagnation? FDA Report.
- Pharmaceutical industry Research or marketing?
- IP and development.
- Technology transfer and FDI
28IP and access to drugs capacity building project
- No trips Plus (FTAs.)
- National legislation on IP sensitive to public
health. (Doha) - Full implementation of flexibilities
- Full use of P 6 Resolution
- South South cooperation on generics
- New international IP RULES?
29(No Transcript)
30(No Transcript)
31Spent (US million) and people on ARV therapy.
Source MOH STD/HIV-AIDS National Program.
Brazil.
323 imported (patented) ARVs mean 63 of total
budget. 2003
12 other ARVs 37
Spent
LPV.r EFZ NFV 63
LPV.r
NFV
EFZ
12 other ARVs
Source MOH STD/HIV-AIDS National Program.
Brazil.
33Average cost of ARV patient/year 1996 - 2003
1630
2003
MS/ 2003
Source MOH STD/HIV-AIDS National Program.
Brazil.